In older people, Atrial fibrillation (AF) is more prevalent and associated with coronary heart disease. Managing patients can be challenging, especially those on antithrombotic therapy and requiring antiplatelet therapy after percutaneous coronary intervention(PCI). A comprehensive assessment of both thrombotic and bleeding risk, and individualized decision-making is imperative to ensure the best clinical outcome for such patients. Hypertension (HTN) must also be managed effectively. To gain expert insights into major cardiovascular conditions, join Dr. Vineet Sankhla, Dr.
Hiren Kevadiya and Dr. Ajay Naik , on 7th September, 3 PM onwards. Highlights: Antithrombotic therapy in AF Patients Undergoing PCI: Where do we stand? Case-based: HTN management from guidelines to practice: What should every doctor know? An update on atrial fibrillation Stay tuned for more! .
